Key Highlights:

• Joint Resolution 1/2026: Repeals restrictive 2012 pharmaceutical patentability guidelines

• Standard Criteria: Resumes full substantive reviews for novelty & inventive step

• Broader Scope: Re-opens protection for formulations, combinations & process claims

• Action: Audit dormant Argentine filings now!

Optimize your LATAM patent strategy! 🛡️💼

#ExyIntellectualProperty #Argentina #INPI #PharmaPatents #IPLaw #Patents #LifeSciences